Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2 (CONTENT2)
A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis
Sponsor: Ipsen
Terminated
Slow recruitment of patients
A PHASE3 clinical study on Overactive Bladder and Urinary Incontinence, this trial is terminated or withdrawn. The trial is conducted by Ipsen and has accumulated 23 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
23 versions recorded-
Nov 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2025 — Nov 2025 [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Sep 2022 — Jul 2024 [monthly]
Terminated PHASE3
▶ Show 18 earlier versions
-
Dec 2021 — Sep 2022 [monthly]
Terminated PHASE3
-
Sep 2021 — Dec 2021 [monthly]
Terminated PHASE3
-
Jan 2021 — Sep 2021 [monthly]
Terminated PHASE3
-
Dec 2019 — Jan 2021 [monthly]
Terminated PHASE3
-
Oct 2019 — Dec 2019 [monthly]
Terminated PHASE3
Status: Completed → Terminated
-
Aug 2019 — Oct 2019 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Feb 2019 — Aug 2019 [monthly]
Active Not Recruiting PHASE3
-
Dec 2018 — Feb 2019 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Oct 2018 — Dec 2018 [monthly]
Recruiting PHASE3
-
Aug 2018 — Oct 2018 [monthly]
Recruiting PHASE3
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE3
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE3
-
Jan 2018 — May 2018 [monthly]
Recruiting PHASE3
-
Nov 2017 — Jan 2018 [monthly]
Recruiting PHASE3
-
Aug 2017 — Nov 2017 [monthly]
Recruiting PHASE3
-
May 2017 — Aug 2017 [monthly]
Recruiting PHASE3
-
Feb 2017 — May 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Jul 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ipsen
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
A Coruña, Spain , Aberdeen, United Kingdom , Antwerp, Belgium , Barcelona, Spain , Bedford, United Kingdom , Bogotá, Colombia , Bonn, Germany , Brussels, Belgium , Buenos Aires, Argentina , Cali, Colombia and 52 more locations